Emmaus Life Sciences, Inc.
EMMA
$0.016
$0.00053.23%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -244.58% | 2,626.87% | -40.18% | -25.99% | 504.50% |
| Total Depreciation and Amortization | -16.67% | -37.50% | -33.33% | -33.33% | -53.85% |
| Total Amortization of Deferred Charges | -89.43% | -88.16% | -89.91% | -15.12% | 40.43% |
| Total Other Non-Cash Items | 58.31% | -8.89% | -42.34% | -102.02% | 28.89% |
| Change in Net Operating Assets | 237.89% | -84.54% | 27.70% | 597.04% | -75.95% |
| Cash from Operations | -66.89% | 155.17% | -123.52% | 110.84% | -38.22% |
| Capital Expenditure | 66.67% | -- | 40.00% | 33.33% | 25.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | 134.61% | -- | 100.00% |
| Cash from Investing | 66.67% | 100.25% | 135.43% | 99.63% | 99.44% |
| Total Debt Issued | -55.48% | -81.19% | 3.30% | -48.36% | 231.82% |
| Total Debt Repaid | 46.07% | 67.07% | 31.73% | -313.16% | -359.42% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,800.00% | -188.66% | 253.59% | -144.61% | -102.94% |
| Foreign Exchange rate Adjustments | -170.59% | 311.11% | 47.37% | -220.00% | -70.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -87.14% | -287.50% | 54.72% | -238.06% | 23.75% |